Clinical Trial Spotlight

Niacin/steroid combination for RVO

Clinical Trials in Practice: The Business of Drug Approval

Participating in clinical trials can be advantageous to both clinicians and their patients

Clinical Trials Update

Coding Q&A

Don’t presume that you can’t break a bundle

Diffuse Retinal Whitening Signifies Acute Retinal Necrosis

Early vitrectomy and silicone oil tamponade may preserve relatively good visual function

Do Alternative Treatments for CNV Have a Place in the Era of VEGF Inhibition?

Focus on ...

Bausch & Lomb's Millennium Vitrectomy Enhancer

Ocular Toxoplasmosis as the Presenting Sign of AIDS

Neuroimaging was instrumental in confirming the diagnosis

Overcoming Myths and Misconceptions in Small-gauge Vitreoretinal Surgery

Recent enhancements have expanded the indications and improved outcomes

Post-vitrectomy Diabetic Vitreous Hemorrhage: Etiology, Clinical Management, and Prevention

Retinal Lasers: Past, Present, and Future

Technological advancement flourished early on, then plateaued. What's in store next? Part 1 of 2

Subspecialty News

“Women in Retina” group and more

By By ReN

The Future of the Academic Ophthalmologist

Therapeutics Update in Noninfectious Uveitis

Upfront

From the editor-in-chief

Clinical Experiences With a New Vitrectomy System

Panelists discuss the newest features of the Bausch & Lomb Millennium Vitrectomy Enhancer — including some remarkable data on flow rate and duty cycle — and how this system compares with others.